AlphaStocks

PARR vs VRTX

As of Sep 20, 2026, Par Pacific Holdings (PARR) scores 8.4/10 and Vertex Pharmaceuticals Inc / MA (VRTX) 5.3/10 on AlphaStocks' five-model composite, so PARR scores higher. PARR trades 26% below its model fair value; VRTX trades 50% above its model fair value.

PARR

PAR PACIFIC HOLDINGS, INC.

8.4

Strong Buy

$84.38

VRTX

VERTEX PHARMACEUTICALS INC / MA

5.3

Consider Buy

$508.29

PARR vs VRTX: Which is the Better Investment?

PAR PACIFIC HOLDINGS, INC. (PARR) scores 8.4/10 while VERTEX PHARMACEUTICALS INC / MA (VRTX) scores 5.3/10 on AlphaStocks' composite model. PAR PACIFIC HOLDINGS, INC. has the higher composite rating of Strong Buy. PAR PACIFIC HOLDINGS, INC. trades further below its estimated fair value.

This comparison is algorithmically generated and is not financial advice.

MetricPARRVRTX
Scores & Fundamentals
Composite Score8.4/105.3/10
RatingStrong BuyConsider Buy
Price$84.38$508.29
P/E Ratio11.8
ROE25.4%
Market Cap$4B$129B
Fair Value$114.00$339.42
Dividend Yield
Sector Rank#2 of 80#99 of 168
Model Verdicts
PiotroskiStrongAttractive
BuffettStrongAttractive
GrahamCautionCaution
LynchStrongLimited Data
GreenblattAttractiveLimited Data
View full PARRanalysis →View full VRTXanalysis →

Related comparisons

Compare any two stocks →

PARR vs VRTX: Which Stock Scores Higher?

PAR PACIFIC HOLDINGS, INC. (PARR) is in the Energy sector; VERTEX PHARMACEUTICALS INC / MA (VRTX) is in Health Care. PARR currently leads with a composite score of 8.4/10 (Strong Buy) compared to VRTX's 5.3/10 (Consider Buy).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer